EXSURE PRIVATE LIMITED

In their own words

None of the current anti-cancer drugs are targeted to the root cause of cancer i.e. cancer stem cells. Although these prohibitively costly drugs effectively target cancer cells, the residual cancer stem cell population (~2% of the total tumor mass) has the potency to regenerate the entire tumor mass leading to tumor relapse. Therefore an effective solution will be to target both cancer cells and cancer stem cells, thereby removing the tumor from ‘its root’. We are developing a holistic affordable targeted drug-delivery vehicle that will not only target cancer cells but also the more resistant cancer stem cells. Our autologous bio-engineered exosomes provide an effective and efficacious mode to deliver anti-cancer drugs directly to tumor cells which will revolutionize cancer treatment not only in India but also in other developing economies. We will harvest autologous exosomes which will be bioengineered to carry chemotherapeutic drugs specifically to the cancer cell and cancer stem cells. Thereby efficiently reducing chemo-induced toxicity and selectively targeting tumor cells. Our USP: 1) This is the only unique solution specifically targeting cancer stem cells, 2) It will reduce chemo-induced cytotoxicity, 3) It will improve relapse-free survival.

Written by the company on its public Startup India profile. Not verified by us.